Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Post by Cmajoron Jul 18, 2020 5:59pm
134 Views
Post# 31285734

Plausible?

Plausible?
FDA are not messing around. If they identify drugs that can drastically increase the survival chances of the unfortunate people that are a victim of the pandemic, they would surely move mountains to get the drugs to those people. Revive might just have come up with one such drug. A drug that could potentially reduce.the inflammation in people's lungs, thus giving them a better shot at survival. Not only survival, but a quicker recovery time and a reduction of pressure on the buckling hospitals. So what? Well, is it really far fetched that the reason for this so called delay in the announcement, is because the FDA have something else in mind for Revive? Maybe, just maybe, they have seen something in this drug. And, the early signs warrant enough confidence just to go straight ahead and treat people. This is a crisis. This is the time for extreme measures to be taken. Please note, this is simply hypothetical. Wild as it may be, stranger things have happened. And these are strange times.
<< Previous
Bullboard Posts
Next >>